Clincosm LogoSign in Get a demo

pancreatic adenocarcinoma

Showing 1 - 25 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • mFOLFIRINOX plus radiotherapy
  • (no location specified)
Nov 21, 2023

Pancreas Cancer, Pancreatic Adenocarcinoma Trial in Verona (Systematic lymphadenectomy)

Recruiting
  • Pancreas Cancer
  • Pancreatic Adenocarcinoma
  • Systematic lymphadenectomy
  • Verona, VR, Italy
    Unit of Pancreatic Surgery - G.B. Rossi Hospital, University of
Nov 15, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE

Enrolling by invitation
  • Pancreatic Adenocarcinoma
  • liquid biopsy
  • Stockholm, Sweden
    Gastrocentrum, KarolinskaUniversity Hospital
Oct 26, 2023

Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Homologous Recombination Deficiency
  • (no location specified)
Oct 18, 2023

HER-2 Expression in Pancreatic Duct Adenocarcinoma

Completed
  • Pancreatic Adenocarcinoma
  • immunohistochemical approach
  • (no location specified)
Sep 20, 2023

Improving Pancreatic Cancer Care by Use of Computational Science

Recruiting
  • Pancreatic Cancer
  • +5 more
  • No interventions
  • Utrecht, Netherlands
    Regional Academic Cancer Center Utrecht
Sep 22, 2023

Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • DaRT seeds insertion
  • (no location specified)
Sep 5, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

EHR-based Pancreatic Cancer Risk Model

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Predictive Cancer Model
  • Pancreatic Cancer Risk Model (PRISM)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 1, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • CTX131
  • Nashville, Tennessee
    Research Site 1
Mar 21, 2023

Treatment Response in Patients With Pancreatic Adenocarcinoma

Not yet recruiting
  • Pancreatic Adenocarcinoma
    • Besançon, France
    • +14 more
    Mar 8, 2023

    The HELPP Score: A Pretreatment Score to Predict Survival in

    Not yet recruiting
    • Pancreatic Adenocarcinoma
      • Vienna, Austria
        Department of General Surgery, Division of Visceral Surgery, Med
      Feb 21, 2023

      Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

      Not yet recruiting
      • Solid Tumor
      • +4 more
      • (no location specified)
      Feb 21, 2023

      Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

      Recruiting
      • Advanced Solid Tumor (Phase 1)
      • +4 more
      • Duarte, California
      • +4 more
      Feb 2, 2023

      Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

      Terminated
      • Gastrointestinal Cancer
      • +8 more
      • Serious Illness Conversation Guide (SICG)
      • Quality of Life (QOL) survey
      • Stanford, California
        Stanford Cancer Center
      Jan 25, 2023

      Pancreatic Adenocarcinoma Trial in Baltimore (TraceIT tissue marker injection)

      Completed
      Has Results
      • Pancreatic Adenocarcinoma
      • TraceIT tissue marker injection
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Jan 20, 2023

      Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Metastatic
      • New York, New York
      • +7 more
      Jan 3, 2023

      Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation

      Not yet recruiting
      • Pancreatic Cancer
      • +3 more
      • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
      • (no location specified)
      Dec 11, 2022

      Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Japan (ASP2138)

      Recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • Santa Monica, California
      • +5 more
      Dec 13, 2022

      Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

      Recruiting
      • Advanced Solid Tumors
      • +11 more
      • Boston, Massachusetts
      • +4 more
      Dec 12, 2022

      Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

      Terminated
      • Pancreatic Adenocarcinoma
      • +2 more
      • Germline genetic testing
      • San Francisco, California
        Invitae SF
      Dec 5, 2022

      Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Resectable Pancreatic Cancer
      • Nab paclitaxel
      • +2 more
      • (no location specified)
      Dec 5, 2022